Published Date: 15 Mar 2023
A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on diagnosing parasomnias!
Late-breaking data from the 2026 ACTRIMS Forum showed that bazedoxifene acetate failed to improve remyelination outcomes in midlife women with relapsing MS, despite a favorable safety profile.
A nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
We Don't Always Know What's 'Best' for Our Patients
2.
Schizophrenia patients are motivated by music therapy.
3.
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
4.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
5.
Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?
1.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
4.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
5.
Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation